Precautions and contraindications.
Most patients can safely implement Low Carb Whole Food changes. However, it may not be safe to implement changes when patients have any of the following health conditions
Glycogen storage disorders
Porphyria
Inborn errors of metabolism such as carnitine, B-oxidation defect, pyruvate carboxylase deficiency.
End-stage liver failure
Patients with cholecystectomy and bowel resections will need to increase fat intake much more slowly vs other patients.
Most medications are safe to continue a low carbohydrate diet. However, as metabolic health improves some medications may need to be reduced or ceased. For example, LCWF changes are associated with reductions in blood pressure, so anti-hypertensive (blood pressure) medications may need to be reduced or ceased. The reduction in blood glucose levels seen with LCWF changes means that diabetes medications need to be reviewed closely as changes are introduced. There is a class of medications called SGLT2 inhibitors (which include Dapagliflozin and Empagliflozin), which are not ideal to continue a low-carbohydrate diet, and these will need to be ceased especially if considering introducing ketogenic dietary changes.